Kador PF - Search Results

1

Catalytic mechanism of aldose reductase studied by the combined potentials of quantum mechanics and molecular mechanics.

Lee YS, Hodoscek M, Brooks BR, Kador PF. Lee YS, et al. Among authors: kador pf. Biophys Chem. 1998 Mar 9;70(3):203-16. doi: 10.1016/s0301-4622(97)00115-4. Biophys Chem. 1998. PMID: 9546197

2

Hydrogen bonding interactions between aldose reductase complexed with NADP(H) and inhibitor tolrestat studied by molecular dynamics simulations and binding assay.

Lee YS, Hodoscek M, Kador PF, Sugiyama K. Lee YS, et al. Among authors: kador pf. Chem Biol Interact. 2003 Feb 1;143-144:307-16. doi: 10.1016/s0009-2797(02)00188-6. Chem Biol Interact. 2003. PMID: 12604217

3

Molecular modeling studies of aldose reductase inhibitors.

Lee YS, Pearlstein R, Kador PF. Lee YS, et al. Among authors: kador pf. J Med Chem. 1994 Mar 18;37(6):787-92. doi: 10.1021/jm00032a011. J Med Chem. 1994. PMID: 8145228

4

Identification of an aldose reductase inhibitor site by affinity labeling.

Kador PF, Lee YS, Rodriguez L, Sato S, Bartoszko-Malik A, Abdel-Ghany YS, Miller DD. Kador PF, et al. Bioorg Med Chem. 1995 Oct;3(10):1313-24. doi: 10.1016/0968-0896(95)00118-z. Bioorg Med Chem. 1995. PMID: 8564397

5

Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.

Lee YS, Chen Z, Kador PF. Lee YS, et al. Among authors: kador pf. Bioorg Med Chem. 1998 Oct;6(10):1811-9. doi: 10.1016/s0968-0896(98)00139-4. Bioorg Med Chem. 1998. PMID: 9839011

6

Rotamers of tolrestat and their binding mode to aldose reductase.

Lee YS, Sugiyama K, Kador PF. Lee YS, et al. Among authors: kador pf. Adv Exp Med Biol. 1999;463:465-72. doi: 10.1007/978-1-4615-4735-8_58. Adv Exp Med Biol. 1999. PMID: 10352720 No abstract available.

7

Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.

Sugiyama K, Chen Z, Lee YS, Kador PF. Sugiyama K, et al. Among authors: kador pf. Biochem Pharmacol. 2000 Feb 15;59(4):329-36. doi: 10.1016/s0006-2952(99)00332-9. Biochem Pharmacol. 2000. PMID: 10644040

8

Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.

Sato S, Sugiyama K, Lee YS, Kador PF. Sato S, et al. Among authors: kador pf. Exp Eye Res. 1999 May;68(5):601-8. doi: 10.1006/exer.1998.0644. Exp Eye Res. 1999. PMID: 10328974

9

Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats.

Kawamura M, Eisenhofer G, Kopin IJ, Kador PF, Lee YS, Tsai JY, Fujisawa S, Lizak MJ, Sinz A, Sato S. Kawamura M, et al. Among authors: kador pf. Biochem Pharmacol. 1999 Aug 1;58(3):517-24. doi: 10.1016/s0006-2952(99)00121-5. Biochem Pharmacol. 1999. PMID: 10424772

10

Aldose reductase: an aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia.

Kawamura M, Eisenhofer G, Kopin IJ, Kador PF, Lee YS, Fujisawa S, Sato S. Kawamura M, et al. Among authors: kador pf. Auton Neurosci. 2002 Mar 18;96(2):131-9. doi: 10.1016/s1566-0702(01)00385-x. Auton Neurosci. 2002. PMID: 11958479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters